慢阻肺治疗最新进展分析

Analysis of the latest progress in the treatment of chronic obstructive pulmonary disease

ES评分 0

DOI 10.12208/j.ijcr.20240554
刊名
International Journal of Clinical Research
年,卷(期) 2024, 8(12)
作者
作者单位

清镇市犁倭镇卫生院 贵州清镇 ;

摘要
以慢阻肺为主的呼吸道疾病是世界十大致死性疾病之一,其疾病特点为呼吸不畅、肺功能损伤、伴随活动耐力降低,同时慢阻肺无法治愈、容易反复发作。慢阻肺对患者自身和家庭以及社会有严重的负面干扰和影响,因此临床强调对患者实施必要治疗。慢阻肺的传统性治疗方法,主要以稳定期和急性加重期为主要。而随着医学的发展,临床针对该病已经呈现出多元化的治疗趋势,其最新进展包含有三联的吸入制剂治疗、共悬浮给药技术、介入疗法-肺减容术、从免疫机制入手实施疫苗治疗等。本文现就慢阻肺治疗最新进展开展综述,以期为慢阻肺更佳治疗效果提供必要思路和方法。
Abstract
Respiratory diseases, mainly chronic obstructive pulmonary disease (COPD), are one of the top ten deadly diseases in the world. Their characteristics include poor breathing, impaired lung function, and reduced activity tolerance. At the same time, COPD cannot be cured and is prone to recurrent attacks. Chronic obstructive pulmonary disease (COPD) has serious negative interference and impact on patients themselves, their families, and society. Therefore, clinical emphasis is placed on implementing necessary treatment for patients. The traditional treatment methods for chronic obstructive pulmonary disease mainly focus on stable phase and acute exacerbation phase. With the development of medicine, clinical treatment for this disease has shown a diversified trend, including the latest advances in triple inhalation therapy, co suspension administration technology, interventional therapy lung volume reduction, and vaccine treatment starting from the immune mechanism. This article provides a review of the latest developments in the treatment of chronic obstructive pulmonary disease (COPD), aiming to provide necessary ideas and methods for better treatment outcomes.
关键词
慢阻肺;最新进展;肺部功能;呼吸系统疾病;免疫制剂;三联药剂
KeyWord
Chronic obstructive pulmonary disease; Latest progress; Pulmonary function; Respiratory system diseases; Immune preparations; Triple agent
基金项目
页码 193-195
  • 参考文献
  • 相关文献
  • 引用本文

李欣*. 慢阻肺治疗最新进展分析 [J]. 国际临床研究杂志. 2024; 8; (12). 193 - 195.

  • 文献评论

相关学者

相关机构